Anna Fink 1, Maximilian Frederik Russe1, Ralph Strecker2, Marcel Dominik Nickel2, Lea Jigme Michel1, Vlad Sacalean1, Kai Falko Kästingschäfer1, David Klemm1, Alexander Rau3, Fabian Bamberg1, Jakob Weiß1, Stephan Rau1
1Department of Diagnostic and Interventional Radiology, University Medical Center Freiburg, Freiburg, Germany
3Department of Neuroradiology, University Medical Center Freiburg, Freiburg, Germany
Presenting Author: Anna Fink
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. 1. Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 7, 851–861 (2022).
2. 2. Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73–84 (2016).
3. 3. Yoshizawa, E. & Yamada, A. MRI-derived proton density fat fraction. J Med Ultrasonics 48, 497–506 (2021).
4. 4. Caussy, C., Reeder, S. B., Sirlin, C. B. & Loomba, R. Noninvasive, Quantitative Assessment of Liver Fat by MRI‐PDFF as an Endpoint in NASH Trials. Hepatology 68, 763 (2018).
5. 5. Dulai, P. S., Sirlin, C. B. & Loomba, R. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. J Hepatol 65, 1006–1016 (2016).
6. 6. Kolokythas, O. et al. T1-weighted Motion Mitigation in Abdominal MRI: Technical Principles, Clinical Applications, Current Limitations, and Future Prospects. RadioGraphics 44, e230173 (2024).
7. 7. Almansour, H. et al. Combined Deep Learning-based Super-Resolution and Partial Fourier Reconstruction for Gradient Echo Sequences in Abdominal MRI at 3 Tesla: Shortening Breath-Hold Time and Improving Image Sharpness and Lesion Conspicuity. Academic Radiology 30, 863–872 (2023).
8. 8. Brendel, J. M. et al. Prospective Deployment of Deep Learning Reconstruction Facilitates Highly Accelerated Upper Abdominal MRI. Academic Radiology 31, 4965–4973 (2024).
9. 9. Rastogi, A. et al. Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study. The Lancet Oncology 25, 400–410 (2024).
10. 10. Almansour, H. et al. Deep Learning-Based Superresolution Reconstruction for Upper Abdominal Magnetic Resonance Imaging: An Analysis of Image Quality, Diagnostic Confidence, and Lesion Conspicuity. Investigative Radiology 56, 509 (2021).
11. 11. Michel, L. J. et al. Deep learning to estimate impaired glucose metabolism from Magnetic Resonance Imaging of the liver: An opportunistic population screening approach. PLOS Digit Health 3, e0000429 (2024).
12. 12. Reeder, S. B. & Sirlin, C. B. Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am 18, 337–357, ix (2010).
13. 13. Wilpert, C. et al. Deep Learning Reconstruction Combined With Conventional Acceleration Improves Image Quality of 3 T Brain MRI and Does Not Impact Quantitative Diffusion Metrics. Invest Radiol 60, 526–534 (2025).
14. 14. Jimenez-Pastor, A. et al. Precise whole liver automatic segmentation and quantification of PDFF and R2* on MR images. Eur Radiol 31, 7876–7887 (2021).
15. 15. Li, S., Wang, Z., Ding, Z., She, H. & Du, Y. P. Accelerated four-dimensional free-breathing whole-liver water-fat magnetic resonance imaging with deep dictionary learning and chemical shift modeling. Quant Imaging Med Surg 14, 2884–2903 (2024).
16. 16. Altmann, S. et al. Ultrafast Brain MRI with Deep Learning Reconstruction for Suspected Acute Ischemic Stroke. Radiology 310, e231938 (2024).